Skip to main content
TipRanks
Go Ultimate75% OFF
NeuroSigma Inc logo

NeuroSigma Inc: Valuation, Funding & Investors

10960 Wilshire Blvd Los Angeles, California 90024, UShttps://www.neurosigma.com/Medical Devices

NeuroSigma is a Los Angeles, California-based bioelectronic medical device company developing technologies to transform medical practice and patients' lives. The company's lead product is the Monarch eTNS System, which is the first non-drug treatment for pediatric ADHD cleared by the FDA. Pipeline indications for the Monarch eTNS System include neurodevelopmental disorders such as autism spectrum disorder (ASD), learning disabilities, and epilepsy.

Leadership & Board

Current Number of Employees
9
Current LinkedIn Followers
680

Latest Estimated Valuation

Total Amount Raised
$1M
Total Funding Rounds
1
Latest Funding Amount
$1M
Latest Funding Round
Investment

Employee Trend

NeuroSigma Inc had 9 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

9Latest Employee Count
0(0.00%)Week-Over-Week Change
05101520Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

NeuroSigma Inc had 680 followers as of November 16, 2026. The number of followers increased by 1 (0.15%) week-over-week.

680Latest Followers Count
1(0.15%)Week-Over-Week Change
0200400600800Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Dec 15, 2025Investment$1.00M―

Investors

Investor NameFunding Round
Checkmate CapitalInvestment

Similar Companies

A snapshot of private companies similar to NeuroSigma Inc, helping you discover and navigate related company profiles.

Related News and Analysis